Keyword Connections

gliptin

Journals

3

1 PloS one

2 annals of surgery

3 european journal of case reports in internal medicine

Research Groups

0

No Research Group Connected

Bibliographies

26

1 Linagliptin-Associated Alopecia and Bullous Pemphigoid.

2 Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis.

3 DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1.

4 Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.

5 Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes.

6 Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI

7 Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial.

8 Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial

9 Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

10 Pharmacokinetic-Pharmacodynamic (Dipeptidyl Peptidase-4 Inhibition) Model to Support Dose Rationale in Diabetes Patients, Including Those with Renal Impairment, for the Once-Weekly Administered Omarigliptin.

11 Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin.

12 Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis.

13 Sitagliptin protects liver against aflatoxin B1-induced hepatotoxicity through upregulating Nrf2/ARE/HO-1 pathway.

14 A ProspectIve, OpeN-Label, Randomized Study Comparing EffIcacy and Safety of Teneligliptin VErsus Sitagliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: INSITES Study.

15 Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin.

16 sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

17 microflora disturbance during progression of glucose intolerance and effect of sitagliptin: an animal study

18 efficacy and safety of teneligliptin

19 teneligliptin in management of type 2 diabetes mellitus

20 New forced degradation products of vildagliptin: Identification and structural elucidation using LC-MS, with proposed formation mechanisms

21 efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin on atherosclerosis, β-cell function, and glycemic control in japanese patients with type 2 diabetes mellitus who are treatment naïve or poorly responsive to antidiabetes agents: a multicenter, prospective observational, uncontrolled study

22 the persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: studies with hk-2 cells in vitro and normal rats in vivo

23 management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin

24 sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals

25 four-point preprandial self-monitoring of blood glucose for the assessment of glycemic control and variability in patients with type 2 diabetes treated with insulin and vildagliptin

26 Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).